Skip to main content
Livermore
Livermore
ZHEN

Freemont Management S.A.

SEC CIK
0001609120
Latest filing
Aug 11, 2026

ABT holding history

Abbott Laboratories in every 13F filed by Freemont Management S.A., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ABT overviewAll 13F holders of ABTFull Q2 2026 holdings

Shares (Q2 2026)
0
Sold out in Q2 2026
Value
$0
% of portfolio
0.0%
Quarters held
20
Since Q1 2021
Holdings of ABT by Freemont Management S.A., by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20260$00.0%−9,700−100.0%Sold outHolders
Q1 20269,700$995.9K0.2%−1,000−9.3%ReducedHolders
Q4 202510,700$1.34M0.3%+7,100+197.2%AddedHolders
Q3 20253,600$482.2K0.4%−27,300−88.3%ReducedHolders
Q2 202530,900$4.20M0.7%+7,200+30.4%AddedHolders
Q1 202523,700$3.14M1.2%+13,700+137.0%AddedHolders
Q4 202410,000$1.13M0.6%00.0%UnchangedHolders
Q3 202410,000$1.14M0.6%+3,180+46.6%AddedHolders
Q2 20246,820$708.7K0.4%−33,200−83.0%ReducedHolders
Q1 202440,020$4.55M0.7%−12,400−23.7%ReducedHolders
Q4 202352,420$5.77M0.7%00.0%UnchangedHolders
Q3 202352,420$5.08M0.8%−8,900−14.5%ReducedHolders
Q2 202361,320$6.69M0.8%00.0%UnchangedHolders
Q1 202361,320$6.21M0.9%00.0%UnchangedHolders
Q4 202261,320$6.73M1.1%00.0%UnchangedHolders
Q3 202261,320$5.93M1.1%−1,500−2.4%ReducedHolders
Q2 202262,820$6.83M1.2%−3,200−4.8%ReducedHolders
Q1 202266,020$7.81M1.2%+66,020NewHolders
Q4 20210$00.0%−95,420−100.0%Sold outHolders
Q3 202195,420$11.3M1.5%−26,600−21.8%ReducedHolders
Q2 2021122,020$14.1M2.0%+27,000+28.4%AddedHolders
Q1 202195,020$11.4M1.9%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.